349 related articles for article (PubMed ID: 23907102)
21. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
22. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
Ueno Y; Kitajima K; Sugimura K; Kawakami F; Miyake H; Obara M; Takahashi S
J Magn Reson Imaging; 2013 Jul; 38(1):154-60. PubMed ID: 23292979
[TBL] [Abstract][Full Text] [Related]
23. [Effects of different computed high b-values on diffusion weighted imaging scores in Prostate Imaging Reporting and Data System version 2 of prostate cancer in peripheral zone].
Wang W; Shao ZH; Zeng JQ; Wu DL; Wang GL; Wang PJ
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3401-3405. PubMed ID: 29179281
[No Abstract] [Full Text] [Related]
24. Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values.
Ueno Y; Takahashi S; Ohno Y; Kitajima K; Yui M; Kassai Y; Kawakami F; Miyake H; Sugimura K
Br J Radiol; 2015 Apr; 88(1048):20140738. PubMed ID: 25605347
[TBL] [Abstract][Full Text] [Related]
25. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
26. Optimization of b-value distribution for four mathematical models of prostate cancer diffusion-weighted imaging using b values up to 2000 s/mm(2): simulation and repeatability study.
Merisaari H; Jambor I
Magn Reson Med; 2015 May; 73(5):1954-69. PubMed ID: 25045885
[TBL] [Abstract][Full Text] [Related]
27. Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.
Feuerlein S; Davenport MS; Krishnaraj A; Merkle EM; Gupta RT
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):155-60. PubMed ID: 25732928
[TBL] [Abstract][Full Text] [Related]
28. How to Improve the Conspicuity of Breast Tumors on Computed High b-value Diffusion-weighted Imaging.
Tamura T; Takasu M; Higaki T; Yokomachi K; Akiyama Y; Sumida H; Nagata Y; Awai K
Magn Reson Med Sci; 2019 Apr; 18(2):119-125. PubMed ID: 30012905
[TBL] [Abstract][Full Text] [Related]
29. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
Park SY; Kim CK; Park BK; Kwon GY
AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
[TBL] [Abstract][Full Text] [Related]
30. [An experimental study on rabbit liver by 3.0 Tesla magnetic resonance diffusion-weighted imaging].
Dong TM; Sun XJ; Xu X; Dai J; Zheng W; An NY; Wang XQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Feb; 34(1):51-7. PubMed ID: 22737720
[TBL] [Abstract][Full Text] [Related]
31. Clinical applications of diffusion-weighted-MRI in prostate cancer.
Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
[TBL] [Abstract][Full Text] [Related]
32. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
Liu X; Zhou L; Peng W; Wang C; Wang H
Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
[TBL] [Abstract][Full Text] [Related]
34. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
35. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
[TBL] [Abstract][Full Text] [Related]
36. Thin-section diffusion-weighted magnetic resonance imaging of the brain with parallel imaging.
Oner AY; Celik H; Tali T; Akpek S; Tokgoz N
Acta Radiol; 2007 May; 48(4):456-63. PubMed ID: 17453529
[TBL] [Abstract][Full Text] [Related]
37. Added value of high-b-value (b = 3000 s/mm2) diffusion-weighted imaging at 3 T in relation to fluid-attenuated inversion recovery images for the evaluation of cortical lesions in inflammatory brain diseases.
Iwashita K; Hirai T; Kitajima M; Shigematsu Y; Uetani H; Iryo Y; Azuma M; Hayashida E; Ando Y; Murakami R; Yamashita Y
J Comput Assist Tomogr; 2013; 37(3):338-42. PubMed ID: 23674002
[TBL] [Abstract][Full Text] [Related]
38. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
[TBL] [Abstract][Full Text] [Related]
39. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
[TBL] [Abstract][Full Text] [Related]
40. Accelerated Breast Diffusion-weighted Imaging Using Multiband Sensitivity Encoding with the CAIPIRINHA Method: Clinical Experience at 3 T.
Biswas D; Hippe DS; Wang Y; DelPriore MR; Zečević M; Scheel JR; Rahbar H; Partridge SC
Radiol Imaging Cancer; 2022 Jan; 4(1):e210063. PubMed ID: 35029517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
